弥漫大B细胞型淋巴瘤,diffuse large B-cell lymphoma
1)diffuse large B-cell lymphoma弥漫大B细胞型淋巴瘤
1.Objective To evaluate the efficacy and toxicity of combination of Rituximab and CHOP regimen in diffuse large B-cell lymphoma(DLBCL).目的研究利妥昔单抗联合CHOP方案治疗弥漫大B细胞型淋巴瘤的疗效和不良反应。
2.Objective To observe the effect and toxicity of rituximab and CHOP regimen(R-CHOP) in the treatment of initially diagnosed diffuse large B-cell lymphoma.目的观察利妥昔单抗联合CHOP方案(R-CHOP)治疗初治弥漫大B细胞型淋巴瘤的疗效以及毒副反应。
英文短句/例句

1.A Clinical Observation of the Therapeutic Effects with R-CHOP Regimen on the Initially Diagnosed Diffuse Large B-Cell LymphomaR-CHOP方案治疗25例初治弥漫大B细胞型淋巴瘤的临床观察
2.Prognostic Evalution of Immunohistochemical Profiles in Diffuse Large B-cell Lymphoma弥漫大B细胞淋巴瘤的免疫表型与预后的关系
3.Diffuse Large B-cell Lymphoma and Mucosa-Associ-ated Lymphoid Tissue Lymphoma:A CT Comparison Study胃弥漫大B细胞淋巴瘤与黏膜相关淋巴组织淋巴瘤CT比较研究
4.Differences of the nuclear morphological parameters in molecular subtypes of diffuse large B-cell lymphoma(DLBCL)弥漫大B细胞淋巴瘤分子亚型的细胞核形态参数的差异
5.An Observation of the Therapeutic Effects with R-CHOP Regimen in Diffuse Large B-cell Lymphoma;R-CHOP方案治疗弥漫大B细胞淋巴瘤的疗效观察
6.The Analysis of Prognostic Factors in 70 Cases of Diffuse Large B-cell Lymphoma70例弥漫大B细胞淋巴瘤相关预后因素的分析
7.The significance of SELDI-TOF-MS technique applied in diffuse large B-cell lymphomaSELDI-TOF-MS在弥漫性大B细胞淋巴瘤中的意义
8.A study of the expression of Bcl-2 and Bcl-6 in diffuse large B-cell lymphoma.Bcl-2、Bcl-6在弥漫大B细胞淋巴瘤中表达的研究
9.State of Chromosome 3q27 and Different Subtypes of Diffuse Large B-cell Lymphoma and Their Prognostic Relation弥漫性大B细胞淋巴瘤3q27染色体状态和不同亚型与预后的关系
10.Immunohistochemical profiles and their prognostic role in diffuse large B-cell lymphoma弥漫大B细胞淋巴瘤的免疫学亚型与预后的关系
11.Short-term efficacy of rituximab-CHOP and CHOP regimens on two subtypes of diffuse large B-cell lymphomaR-CHOP和CHOP方案治疗两种亚型弥漫大B细胞淋巴瘤患者的近期疗效
12.Clinical observation on rituximab combined with chemotherapy in the treatment of diffused large B cell lymphoma利妥昔单抗联合化疗治疗弥漫型大B细胞淋巴瘤的临床观察
13.Investigation of Protein Expression in Follicular Lymphoma and Diffuse Large B-cell Lymphoma;滤泡性淋巴瘤和弥漫性大B细胞淋巴瘤的蛋白表达研究
14.Expressions of bcl-6,lpp and miR-28 Genes in Diffuse Large B Cell Lymphoma Cell Lines弥漫大B细胞淋巴瘤细胞系中bcl-6、lpp和miR-28基因表达的研究
15.Expression and Significance of Pokemon in Diffuse Large B-Cell Lymphoma and Multiple MyelomaPokemon在弥漫性大B细胞淋巴瘤和多发性骨髓瘤中的表达和意义
16.Clinical Significance of the Expression of Skp2, P27 and Ki67 in Diffuse Large B-Cell Lymphoma;SKP2、P27及Ki67在弥漫性大B细胞淋巴瘤中表达的临床意义
17.Study on the Interrelationship of LGT and the Prognosis of Patients with Diffused Large B Cell Lymphoma;LGT蛋白组与弥漫大B细胞淋巴瘤患者预后相关性的研究
18.Clinical Investigation of Rituximab in Combination with CHOP Chemotherapy for Diffuse Large B Cell Lymphoma;美罗华联合化疗治疗弥漫性大B细胞淋巴瘤的临床研究
相关短句/例句

diffuse large B-cell lymphoma弥漫大B细胞淋巴瘤
1.PRDM1 expression and prognostic value in patients with diffuse large B-cell lymphoma;PRDM1在弥漫大B细胞淋巴瘤中表达和预后意义的研究
2.The molecular cytogenetic aberration analyzed by comparative genomic hybridization and its significance in diffuse large B-cell lymphoma;用比较基因组杂交技术研究弥漫大B细胞淋巴瘤分子细胞遗传学异常及其意义(英文)
3.Immunohistochemical profiles and their prognostic role in diffuse large B-cell lymphoma弥漫大B细胞淋巴瘤的免疫学亚型与预后的关系
3)diffuse large B-cell lymphoma弥漫性大B细胞淋巴瘤
1.Prognosis of R-CHOP regimen in treatment of young adult patients with diffuse large B-cell lymphoma;R-CHOP方案治疗年轻弥漫性大B细胞淋巴瘤患者预后分析
2.Progress in the diagnosis and treatment of diffuse large B-cell lymphoma;弥漫性大B细胞淋巴瘤诊治进展
4)diffuse large B cell lymphoma弥漫大B细胞淋巴瘤
1.Analysis of the prognosis of 96 cases with diffuse large B cell lymphoma(DLBCL);弥漫大B细胞淋巴瘤96例临床及预后分析
2.This study was purposed to explore the expressions of bcl-6,lpp and miR-28 genes in diffuse large B cell lymphoma(DLBCL) cell lines at the levels of gene and protein,and the relationship between them.本研究从基因和蛋白水平探讨弥漫大B细胞淋巴瘤(DLBCL)细胞系中Bcl-6、LPP和miR-28表达,及其之间的相互关系。
5)diffuse large B cell lymphoma弥漫性大B细胞淋巴瘤
1.Clinicopathological observation of diffuse large B cell lymphoma and study of origin of its B cell;弥漫性大B细胞淋巴瘤的临床病理观察及其B细胞来源分析
2.Research on relation of expression of drug resistance-related genes in diffuse large B cell lymphomas and clinical individualized chemotherapy;耐药相关基因在弥漫性大B细胞淋巴瘤中的表达与其个体化药物治疗方法的探讨
3.Expression of drug resistance-related genes in diffuse large B cell lymphoma and their clinical significance;化疗耐药相关基因在弥漫性大B细胞淋巴瘤中的表达及其临床意义
6)DLBCL弥漫大B细胞淋巴瘤DLBCL
延伸阅读

弥漫型胸膜间皮瘤弥漫型胸膜间皮瘤diffuse mesothelioma of pleura 胸膜间皮瘤的一种类型,参见“胸膜间皮瘤”。